Using AI to accelerate biomarker driven drug discovery in Glioblastoma: a proof of concept for the GBM-CoDE platform using arrayed phenotypic CRISPRi screening.

Project Details

StatusFinished
Effective start/end date1/03/2230/09/24

Funding

  • UK-based charities: £18,157.00